Wee1

ProteinWikipedia

12

MENTIONS

2

EPISODES

2

PODCASTS

Oct 1, 2026

Oncology Today with Dr Neil Love

HER2-Positive Gynecologic Cancers — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Oct 1 · 6 Mentions

Ursula MatulonisSOUNDBITE_SPEAKER

1:58

So my question to the esteemed panel would be, now that she has had progression, what would you treat her with? I'd also love to hear from the panel what other really interesting and unique options for therapies are available for an endometrial serous cancer.

Ursula MatulonisSOUNDBITE_SPEAKER

2:16

Love to hear from Dr. Liu about the use of WEE1 inhibitors.

Ursula MatulonisSOUNDBITE_SPEAKER

2:21

This lady has done really well from a gastrointestinal standpoint and really remarkably well with T-DXd, probably one of the individuals who has the best tolerance of this agent.

Ursula MatulonisSOUNDBITE_SPEAKER

2:31

She recently was switched to weekly paclitaxel, and unfortunately has had pretty significant GI toxicities.

Neil LoveHOST

2:43

Um, so all right.

Neil LoveHOST

2:47

Let's talk about some of the agents post-ADCs that you're excited about before we get to some of the other questions.

Neil LoveHOST

2:54

And she asked some, like, WEE1 inhibitors, for example.

Neil LoveHOST

2:57

So what's some of the stuff that y- you're looking in this post-ADC world? And I'm gonna have a follow-up question after that.

Gynecologic Oncology Update

HER2-Positive Gynecologic Cancers — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Oct 1 · 6 Mentions

Ursula MatulonisSOUNDBITE_SPEAKER

1:58

So my question to the esteemed panel would be, now that she has had progression, what would you treat her with? I'd also love to hear from the panel what other really interesting and unique options for therapies are available for an endometrial serous cancer.

Ursula MatulonisSOUNDBITE_SPEAKER

2:16

Love to hear from Dr. Liu about the use of WEE1 inhibitors.

Ursula MatulonisSOUNDBITE_SPEAKER

2:21

This lady has done really well from a gastrointestinal standpoint and really remarkably well with T-DXd, probably one of the individuals who has the best tolerance of this agent.

Ursula MatulonisSOUNDBITE_SPEAKER

2:31

She recently was switched to weekly paclitaxel, and unfortunately has had pretty significant GI toxicities.

Neil LoveHOST

2:43

Um, so all right.

Neil LoveHOST

2:47

Let's talk about some of the agents post-ADCs that you're excited about before we get to some of the other questions.

Neil LoveHOST

2:54

And she asked about WEE1 inhibitors, for example.

Neil LoveHOST

2:57

So what's some of the stuff that y- you're looking in this post-ADC world? And I'm gonna have a follow-up question after that.

Wee1

Oct 1, 2026

We value your privacy